SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-20-001952
Filing Date
2020-06-15
Accepted
2020-06-15 17:02:57
Documents
1
Period of Report
2020-06-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5464
  Complete submission text file 0001683168-20-001952.txt   6825
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Issuer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O MEDICINOVA, INC. 4275 EXECUTIVE SQUARE, SUITE 650 LA JOLLA CA 92037
Business Address
Matsuda Kazuko (Reporting) CIK: 0001531140 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33185 | Film No.: 20964087